A biofilm activator MmtA1 modulates multi-drug resistance in mycobacteria

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-03 · read from full text

The paper investigates how Mycobacterium species form antibiotic-induced biofilms and multidrug resistance, focusing on the transcriptional factor MmtA1 and its response to the anti-tuberculosis drug isoniazid. Using M. smegmatis, the authors report that MmtA1 regulates genes involved in sugar and lipid transportation, and that this regulatory activity increases biofilm formation and multidrug resistance after isoniazid exposure. A key caveat is that the study characterizes these mechanisms in a model mycobacterium (M. smegmatis) rather than directly in Mycobacterium tuberculosis or in human disease tissue. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

When exposed to the antibiotic-induced stress, Mycobacterium species have the ability to survive by forming protective multicellular structures known as biofilms. However, the underlying mechanism of biofilm formation in response to antibiotics is not fully understood. In this study, we identified a transcriptional factor, MmtA1, which responds to the first-line anti-tuberculosis drug isoniazid and regulates genes involved in sugar and lipid transportation. This leads to increased biofilm formation and multi-drug resistance in M. smegmatis . These findings suggest that isoniazid may act as a molecular messenger, working in coordination with transcriptional regulatory factors to induce multidrug resistance under chemotherapy. Importance This study elucidates a novel transcriptional regulatory mechanism by which Mycobacterium smegmatis develops multidrug resistance in response to the anti-tuberculosis drug isoniazid. By linking antibiotic stress to transcriptional regulation and metabolic adaptation, this work provides new insights into drug-induced tolerance in mycobacteria, suggesting antibiotic functional as inducer of biofilm formation, triggering a coordinated transcriptional response to enhance bacterial survival under antibiotic pressure.
Full text 1,271 characters · extracted from oa-doi-fallback · click to expand
Abstract When exposed to the antibiotic-induced stress, Mycobacterium species have the ability to survive by forming protective multicellular structures known as biofilms. However, the underlying mechanism of biofilm formation in response to antibiotics is not fully understood. In this study, we identified a transcriptional factor, MmtA1, which responds to the first-line anti-tuberculosis drug isoniazid and regulates genes involved in sugar and lipid transportation. This leads to increased biofilm formation and multi-drug resistance in M. smegmatis. These findings suggest that isoniazid may act as a molecular messenger, working in coordination with transcriptional regulatory factors to induce multidrug resistance under chemotherapy. Importance This study elucidates a novel transcriptional regulatory mechanism by which Mycobacterium smegmatis develops multidrug resistance in response to the anti-tuberculosis drug isoniazid. By linking antibiotic stress to transcriptional regulation and metabolic adaptation, this work provides new insights into drug-induced tolerance in mycobacteria, suggesting antibiotic functional as inducer of biofilm formation, triggering a coordinated transcriptional response to enhance bacterial survival under antibiotic pressure.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-29T02:00:03.542394+00:00
License: CC-BY-4.0